Insulin Lizpro na aha ahia ya

ihe ngwọta maka nchịkwa intravenous na subcutaneous

1.0 ml nke usoro ọgwụgwọ intravenous na subcutaneous management nwere:
ike ọrụ: Lyspro Insulin 100 ME (3.47 mg),
ndị na-ebu ụzọ: zinc oxide 25 μg, sodium phosphate weghaara 1.88 mg, glycerol 16 mg, metacresol 3.15 mg, hydrochloric acid ka pH 7.0-7.8, sodium hydroxide ka pH 7.0-7.8, mmiri maka injection ruru 1.0 ml.

Mpempe ọnya na-enweghị ntụpọ.

Ngwongwo ogwu

Lyspro insulin bu nnuku ihe mmadu na - eme na insulin. Ọ dị iche na insulin nke mmadụ na usoro amino asịd nọ n'ọnọdụ 28 na 29 nke insulin B yinye.

Mlọ ọgwụ
Ihe bụ ọrụ insulin lyspro bụ nhazi nke metabolism metabolism. Na mgbakwunye, ọ nwere anabolic na mgbochi catabolic na anụ ahụ dị iche iche. Na akwara anụ ahụ, enwere mmụba nke ọdịnaya glycogen, abụba abụba, glycerol, mmụba na njikọta protein na mmụba nke oriri amino acid, mana mbelata nke glycogenolysis. gluconeogenesis, ketogenesis. lipolysis, protein catabolism na mwepụta nke amino asịd.
Egosiputara na insulin lyspro dabara na insulin nke mmadu, mana ihe o mere na-adi ngwa ngwa, o wee rue obere oge.
A na - amata insulin Lyspro site na nmalite ngwa ngwa (ihe dị ka nkeji iri na ise), ebe ọ bụ na ọ nwere oke mmịpụta, nke a na - enye gị ohere ịbanye na ya tupu nri (0-15 nkeji tupu nri), n'adịghị ka insulin na-eme obere oge. Insulin Lyspro na-arụpụta ọrụ ya ngwa ngwa ma nwee obere oge ọrụ (site na awa abụọ ruo awa ise), ma e jiri ya tụnyere insulin mmadụ nkịtị.
N'ime ndị ọrịa nwere ụdị 1 mellitus nke ọrịa shuga, hyperglycemia nke na-apụta mgbe ị withụchara insulin lyspro na-ebelata nke ukwuu ma e jiri ya tụnyere insulin na-arịa ọrịa.
Dị ka ọ dị na nhazi insulin niile, oge nke lyspro insulin eme ihe nwere ike ịdị iche na ndị ọrịa dị iche iche ma ọ bụ n'oge dị iche iche na otu onye ọrịa ahụ ma dabere na ntanetị, saịtị ịgba ahụ, inye ọbara, ọnọdụ ahụ yana ọrụ ahụ.
Omume ọgwụ na-agbanwe dị na insulin insulin n'ime ụmụaka na ndị nọ n'afọ iri na ụma yiri nke a hụrụ na ndị okenye.
Ojiji nke inspores lyspro n'ime ndị ọrịa nwere ụdị 1 na ụdị ọrịa shuga 2 na-esochi ibelata ugboro ole a na-enwekarị hypoglycemia ma e jiri ya tụnyere insulin mmadụ na-arịa. Nzaghachi glucodynamic dị na insulin nke lispro nọọrọ onwe ya na ọrụ akụrụngwa ma ọ bụ ọrụ hepatic.

Mlọ ọgwụ
Mgbe nchịkwa subcutaneous gasịrị, a na-etinye insulin Lyspro ngwa ngwa wee ruo na ntinye plasma kachasị mgbe nkeji 30-70 gasịrị.
Site na nchịkwa subcutaneous, ọkara ndụ insulin lispro bụ ihe dị ka elekere 1.
N'ime ndị ọrịa nwere akụrụ gbasara akwara, enwere mmụba dị elu nke nnabata nke insịl lyspro ma e jiri ya tụnyere insulin mmadụ na-arịa ya. N'ime ndị ọrịa nwere ọrịa shuga nke 2, ọdịiche ọgwụ dị n'etiti insulin lispro na insulin na -akpata mmadụ nwere onwe ya na ọrụ ezumike.
Ndị ọrịa nwere oke ịba ọcha n'anya nwere oke mmịpụta dị elu na mwepụ nke insulin lispro ngwa ngwa karịa insulin na -akpata mmadụ.

Jiri n'oge ime na n'oge nri siri ike

Ime
Ọtụtụ data banyere ojiji nke insulin lispro n'oge afọ ime na-egosi enweghị mmetụta nke ọgwụ ahụ n'oge ime ma ọ bụ ọnọdụ nwa ebu n'afọ na nwa amụrụ ọhụrụ.
N'oge afọ ime, isi ihe bụ ijikwa glycemic njikwa na ndị ọrịa nwere ọrịa shuga na-anata insulin. Mkpa insulin na-ebelata n'oge ọkara nke mbụ ma na-abawanye n'oge ọkara nke abụọ na nke atọ. N'oge na mgbe amuchara nwa, ihe insulin chọrọ nwere ike ịda nke ọma. Ndị ọrịa nwere ọrịa shuga kwesịrị ịkpọtụrụ dọkịta ma ọ bụrụ na ime emee ma ọ bụ na-eme atụmatụ. N'ihe gbasara ịtụrụ ime na ndị ọrịa nwere ọrịa shuga, isi ihe bụ ileba anya n'ọtụtụ glucose n'ọbara, yana ọnọdụ ahụike n'ozuzu ya.
Oge ara
Ndị ọrịa n’oge ị na-a breastụ ara nwere ike ịhazigharị usoro usoro insulin, nri, ma ọ bụ ha abụọ.

Usoro onunu ogwu na nhazi

Ọgwụ nke ọgwụ insulin Lyspro bụ nke dọkịta kpebiri n’otu n’otu, dabere n’obara glucose dị n’ọbara. Usoro nchịkwa insulin dị iche iche.
Enwere ike inye insulin Lyspro ọgwụ ahụ obere oge tupu nri (0-15 nkeji tupu nri). Ọ bụrụ na ọ dị mkpa, enwere ike ịnye ọgwụ insulin Lyspro obere oge mgbe nri gasịrị.
Okpomọkụ dị iche iche nke ọgwụ a na-elekọta kwesịrị ịdị na n ụlọ ahụ.
Ekwesịrị ịnye ọgwụ insulin Lyspro dị ka injections subcutaneous ma ọ bụ nchịkwa subcutaneous ogologo oge yana mgbapụta insulin. Ọ bụrụ na ọ dị mkpa (ketoacidosis, ọrịa siri ike, oge dị n'etiti arụmọrụ ma ọ bụ oge ọrụ oge), enwere ike ịnye ọgwụ insulin Lyspro intravenously.
Ekwesịrị ka abanye ya n'ubu, apata ụkwụ, aka ekpe ma ọ bụ n'afọ. Ekwesịrị ịgbanye saịtị ndị injection ahụ ka ejiri otu ebe ahụ karịa ihe dịka oge 1 kwa ọnwa. Site na nchịkwa subcutaneous nke ọgwụ insulin Lyspro, a ga-akpachara anya iji zere ọgwụ na-abanye n'ọbara ọbara. Mgbe ogwu ogbugba gasịrị, ekwesighi ịhịa aka ntụtụ. E kwesiri inye onye ọrịa ọzụzụ n'ụzọ ziri ezi.

Ntuziaka maka nhazi nke ọgwụ insulin lispro
a) Nkwadebe maka mmeghe
Ngwọta nke ọgwụ insulin Lyspro kwesịrị ịpụta ìhè na enweghị agba. Ejila insulin Lyspro mee ihe ma ọ bụrụ urukpuru, na-acha odo odo, na-enweghị ike, ma ọ bụ ọ bụrụ na achọpụtara ururu ihe na-ahụ anya.
Mgbe ị na-etinye katriji na pen sirinji, na-agbakwunye agịga ma na-abanye insulin, soro ntuziaka onye nrụpụta nke agụnyere na mkpịsị ọ bụla sirinji. Enwere ike iji Cartridges nwere Insulin Lyspro jiri EndoPen sirinji pensụ nke Beijing Gangan Technology Co., Ltd., China mepụtara. Enweghi ike iji mkpịsị mkpụrụ osisi ndị ọzọ sụgharịa mkpụrụ osisi maka iji ya ugboro ugboro, ebe ọ bụ na edebere izi ezi nke ọgwụ ahụ naanị maka mkpịsị sirinji ndị dị n'elu.
b) dosing
1. Saa aka gi.
2. Họrọ ebe igba ogwu.
3. Kwadebe anụ ahụ na saịtị ịgba ọgwụ dịka dọkịta gị gwara gị.
4. Wepu okpu nchedo site na agịga.
5. Mechie anụahụ.
6. Tinye mapaya n'okpuru ma mee ntụtụ ahụ dabere na ntuziaka maka iji sirinji sirinji.
7. Wepu agịga ahụ ma jiri nwayọọ sụchaa ebe ịgba ọgwụ ntụtụ ahụ ruo ọtụtụ sekọnd. Etekwala ebe a na-agba ntụtụ.
8. Iji okpu agịga mpụga, wepụpụ agịga ma kpofu ya.
9. Tinye okpu na pen sirinji.
c) Nlekọta intulin
A ga-emerịrị ọgwụ mgbochi irighiri ọgwụ ọgwụ insulin Lyspro dabere na omume ịgba ọgwụ mgbochi irighiri akwara dị na mbụ, dịka ọmụmaatụ, nchịkwa mgbochi bolus ma ọ bụ jiri usoro ịgba ume. N'okwu a, ọ na-adịkarị mkpa ịchịkwa mkpokọta glucose na ọbara.
Ngwunye mkpụrụ ndụ na-etinye ọnụ site na 0.1 IU / ml ruo 1.0 IU / ml nke insulin lispro na 0.9% sodium chloride solution ma ọ bụ 5% dextrose ngwọta kwụsiri ike na ọnụ ụlọ maka 48 awa.
d) Nchịkwa insulin na-eji insulin na-arụ ọrụ
Maka ntinye nke ọgwụ insulin Lyspro, ị nwere ike iji nfuli - sistemụ maka nchịkwa insulin na-aga n'ihu na insulin akara. Tupu ị ghee insulin lyspro, gbaa mbọ hụ na otu ọkpọkọ kwesịrị ekwesị. Kwesịrị ịgbasochi ntuziaka ndị ahụ soro na mgbapụta. Jiri akwa mmiri na catheter kwesịrị ekwesị maka mgbapụta ahụ. Ekwesịrị ịgbanwe gbanwee insulin ahụ dịka ntuziaka ndị enyere ngwa a si agbanwe. N'ihe banyere njikọ hypoglycemic, a na-akwụsị nchịkwa ruo mgbe ihe ahụ ga-edozi. Ọ bụrụ na ekwenyela na itinye glucose dị ala n'ọbara, mgbe ahụ ọ dị mkpa ịgwa dọkịta banyere nke a ma nye ma belata ma ọ bụ kwụsịlata nchịkwa insulin. Mgbapụta ikuku ma ọ bụ mgbochi na sistemụ nchịkwa nwere ike ibute mmụba ngwa ngwa glucose. Maka enyo enyo ma mebie insulin, ị ga-eso ndụmọdụ ndị ahụ, ma ọ bụrụ na ọ dị mkpa, gwa dọkịta.
Mgbe ị na-eji mgbapụta mmiri, ekwesighi ịgwakọta insulin Lyspro na insulins ndị ọzọ.

Nsonaazụ

Hypoglycemia bụ nsonaazụ kachasị emetụta ndị mmadụ na - achọghị ka ọgwụgwọ ndị ọrịa kansa na - arịa ọrịa insulin. Nnukwu hypoglycemia nwere ike ibute ọnwụ nke mmụọ (hypoglycemic coma) na. n'ọnọdụ ndị pụrụ iche, ọnwụ.
Ndị ọrịa nwere ike inweta mmeghachi omume nfụkasị obodo n'ụdị nchapu ọbara, ọzịza, ma ọ bụ itching na ntụtụ ebe. N ’oge a, mgbaàmà ndị a na-apụ n’anya n’ime ụbọchị ole na ole ma ọ bụ izu ole na ole. Ọ na-esikarị ike mmeghachi omume nfụkasị ahụ, na nke itching nwere ike ime na ahụ dum, urticaria, angioedema, ahụ ọkụ, mkpụmkpụ ume, mbelata ọbara mgbali, tachycardia. amata aja aja. Ọnọdụ ndị siri ike nke mmeghachi omume nfụkasị ara na-akpata nwere ike itinye ndụ egwu.
Ebe injection nwere ike ịmalite lipodystrophy.
Ozi n'amaghi ama:
A mara ọkwa nke mmepe edema, nke mepụtara tumadi ka ọ gbasasịrị ọsọ glucose ọbara n'ọbara n'oge ọgwụgwọ kpụ ọkụ n'ọnụ na njikwa glycemic na-enweghị afọ ojuju (lee mpaghara “Ntuziaka Pụrụ Iche”).

Dodoụbiga ya ókè

Ọrịa ịdoụbiga ihe ọ isụ accompaniedụ na-esonyere mmepe nke mgbaàmà hypoglycemia: ike ọgwụgwụ, ịsụsọ nke ukwuu, agụụ, ịma jijiji, tachycardia, isi ọwụwa, ọgbụgbọ, ọgbụgbọ, ọgba aghara.
Ọgwụgwọ: A na-akwụsị oge dị ala hypoglycemic site na ịba ụba nke glucose ma ọ bụ shuga ndị ọzọ, ma ọ bụ ngwaahịa nwere shuga (a na-atụ aro ka gị na glucose dịkarịa ala 20 mgbe ọ bụla).
Enwere ike ịme mmezi hypoglycemia dị mkpirikpi site na iji intramuscular ma ọ bụ nchịkwa subcaneous nke glucagon, ntinye nke carbohydrates na-esote ọnọdụ ahụike nke onye ọrịa. A na-eji ọgwụ dextrose (glucose) na-agwọ ndị ọrịa ekweghị anabata glucagon.
Ọ bụrụ na onye ọrịa ahụ nọ na nsogbu, mgbe ahụ, a ga-enye glucagon intramuscularly ma ọ bụ subcutaneously. Enweghị glucagon ma ọ bụ ọ bụrụ na mmeghachi omume adịghị na ntinye ya, ọ dị mkpa ka ịzie usoro dextrose intravenain. Ozugbo ọ matara onwe ya, a ga-enyerịrị onye ọrịa ahụ nri nwere carbohydrate.
Enwere ike ịchọ nkwado ọzọ nke carbohydrates na nyocha onye ọrịa, ebe ọ bụ na enwere ike ndọghachi hypoglycemia ga-ekwe omume.
Banyere hypoglycemia bufere ọ dị mkpa ịgwa ndị dibịa bekee.

Mmekọrịta na ọgwụ ndị ọzọ

A na-ebelata ogo mmetụta hypoglycemic mgbe ejikọtara ya na ọgwụ ndị a: ọgwụ mgbochi, glucocorticosteroids, iodine nwere homonụ thyroid, danazol, β₂-adrenomimetik (dịka ọmụmaatụ, ritodrin, salbutamol, terbutaline), tricyclic antidepressants, thiazide diuretics, chlorprotixen, diazoxide, isoniazid, carbon lithium, nicotinic acid, ọgwụ phenothiazine.
Ọnọdụ hypoglycemic dị elu na-abawanye mgbe ejiri ya na ọgwụ ndị a: ọgwụ beta-blockers, ethanol na ethanol nwere ọgwụ, anabolic steroid, fenfluramine, guanethidine, tetracyclines, ọgwụ hypoglycemic nke ọgwụ, salicylates (dịka ọmụmaatụ, acetylsalicylic acid antioxidants, sulfonamides, sulfonamides, sulfonamides ), angiotensin na - agbanwe enzyme inhibitors (captopril, enalapril), octreotide, angio receptor antagonists Tenzin II.
Ọ bụrụ na ịchọrọ iji ọgwụ ndị ọzọ, na mgbakwunye na insulin, ị ga-agakwuru dọkịta gị (lee akụkụ "ntuziaka pụrụ iche").

Ntụziaka pụrụ iche

Ekwesịrị inyefe onye ọrịa n'ọtụtụ ma ọ bụ ịkwadebe insulin n'okpuru nlekọta ahụike siri ike. Mgbanwe na arụmọrụ, ika (emeputa), ụdị (gulargachi, NPH, wdg), ụdị (anụmanụ, mmadụ, analog nke insulin mmadụ) na / ma ọ bụ usoro mmepụta (DNA insulin ma ọ bụ insulin nke anụmanụ sitere) nwere ike ibute. na ịchọrọ ị changeụ ọgwụ.
N'ime ndị ọrịa nwere mmeghachi omume hypoglycemic mgbe ebufere site na insulin sitere na anụmanụ na insulin nke mmadụ, mgbaàmà mmalite nke hypoglycemia nwere ike ọ gaghị akpọpụta ma ọ bụ dị iche na ndị nwere insulin ha na mbụ. Ekwesịrị iburu n'uche na nsonaazụ nke ọgwụ ọgwụ nke analogues nke insulin na-eme mmadụ ngwa ngwa bụ na ọ nwere ike ịmalite mgbe ejiri ọgwụ insulin na-eme ngwa ngwa mmadụ karịa oge ejiri insulin na-arụ ọrụ mmadụ.
Maka ndị ọrịa na-anata insulins dị mkpụmkpụ ma na-enwe isi, ọ dị mkpa ịhọrọ ọnụọgụ nke insulins iji wee nweta oke glucose n'ọbara n'ụbọchị, ọkachasị n'abalị ma ọ bụ na afọ efu.
Mmeghachi omume hypoglycemic ma ọ bụ mmeghachi omume hyperglycemic nwere ike ime ka ọnwụ nke mmụọ, ma ọ bụ ọnwụ nwụọ.
Mgbaàmà nke hypoglycemia nwere ike gbanwee ma ọ bụ belata ka ọ dị ogologo oge na ọrịa mellitus, ọrịa mamịrị ma ọ bụ iji ọgwụ dịka beta-egbochi.
Ọgwụ ezughị ezu ma ọ bụ ịkwụsị ọgwụgwọ, karịsịa na ndị ọrịa nwere ụdị ọrịa shuga 1, nwere ike ibute ọrịa hyperglycemia na ketoacidosis, ọnọdụ ndị nwere ike igbu onye ọrịa.
Mkpa insulin nwere ike belata na ndị ọrịa nwere ọdịda akụrụ, yana ndị ọrịa nwere ọrịa imeju n'ihi mbelata usoro gluconeogenesis na metabolism metabolism. Agbanyeghị, na ndị ọrịa nwere ọrịa imeju na-adịghị ala ala, mmụba nke insulin na-aba ụba nwere ike iduga n'ọtụtụ insulin.
Mkpa insulin nwere ike ịbawanye na ọrịa ụfọdụ, ma ọ bụ nrụgide mmetụta uche.
Ọ nwekwara ike ịdị mkpa iji dozigharị azụ mgbe ndị ọrịa na-amụba mmega ahụ ma ọ bụ mgbe ha na-agbanwe nri kwesịrị ekwesị. Mmega ahụ nwere ike ibute oke ọrịa hypoglycemia.
Mgbe ị na-eji nkwadebe insulin yana ọgwụ ọgwụ thiazolidinedione, ihe ize ndụ nke ịmalite ọrịa edema na obi na-adịghị ala ala na-abawanye, karịsịa na ndị ọrịa nwere ọrịa obi na ọrịa ọnụnọ nke ihe ize ndụ maka ọdịda obi na-adịghị ala ala.
Ojiji insulin lispro n'ime ụmụaka kama insulin na-agwọ mmadụ dị mma n'ọnọdụ ndị ahụ mgbe ọ dị mkpa ịmalite ngwa ngwa insulin (dịka ọmụmaatụ, iwebata insulin ozugbo nri).
Iji gbochie ọrịa nwere ike ibute ọrịa, ọ bụ naanị otu onye ọrịa ga-eji plọg / pen ọ bụla rụọ ya, ọ bụrụgodi na-anọchi agịga.

Ozi izugbe

A na-ere insulin Lyspro n'okpuru aha azụmahịa Humalog. Enwere ike ịzụta ọgwụ a na katalọgụ hypodermic ma ọ bụ na-agba ntụtụ. Ọ, n'adịghị ka ọgwụ na katriji, enwere ike ịhazi ya ọ bụghị naanị subcutaneously, kamakwa intravenously na intramuscularly. N'agbanyeghi eziokwu na enwere ike ịgwakọta ọgwụ a n'otu sirinji yana insulin na-arụ ọrụ ogologo oge, ọ ka mma ịghara ime nke a ma jiri ngwaọrụ onwe onye maka ọ bụla. Nke bụ eziokwu bụ na ihe enyemaka nke ọgwụ ike nwere ike ị bata na mmeghachi omume a na-atụghị anya ya wee duga nsonaazụ, nsị, ma ọ bụ ibelata ịdị mma nke ihe ndị na-arụ ọrụ.

Ọ bụrụ na onye ọrịa ahụ nwere ọrịa na-adịghị ala ala nke ịchọrọ ị medicationsụ ọgwụ ndị ọzọ oge niile, ị ga-eme ka ịgwa endocrinologist banyere nke a. Lyspro insulin ekwekọghị na ọgwụ ụfọdụ nke ọbara mgbali elu na nnukwu ethanol. Mmetụta hypoglycemic ya nwere ike belata ọgwụ homonụ nke ukwuu maka ọgwụgwọ nke gland thyroid, psychotropic ọgwụ na ụfọdụ diuretics (diuretics).

Enwere ike iji ọgwụ a gwọọ ndị ọrịa nwere ụdị ọrịa dị iche iche. Dịka iwu, a na-anabata ya nke ọma ma ọ na-akpatakarị nsonaazụ ndị ọzọ. Isi ihe eji egosi ya

• ụdị shuga 1 (ọkachasị ndị ọrịa enweghị nnabata nke insulin ndị ọzọ),
• mmụba na shuga mgbe nri gachara, nke ọgwụgwọ ndị ọzọ agaghị edozigharị,
• oke oruru oria abuo
• ụdị shuga abụọ nke siri ike, ọ bụrụhaala na-enwechaghị mmetụta nke mbadamba shuga na nri nri,
• mgbochi nke nsogbu na ndị ọrịa nwere ụdị ọria ọ bụla nwere oke ịwa ahụ.

Ekele site na molekul mkpụrụ ndụ ihe ọmụmụ gbanwetụrụ na ọgwụ a, Humalog gosipụtara mmetụta ọgwụ zuru oke ọbụlagodi ụdị ndị ọrịa mamịrị.

Njirimara ngwa

Dọkịta ahụ chọrọ ka dọkịta lyspro insụta kwesịrị ịhọrọ ya, ebe ọ bụ ihe dịịrị onye ọrịa ọ bụla. Nanị mmachi bụ na agaghị enwe ike ịnwe ihe karịrị nkeji 40 nke ọgwụ otu oge. Ing gafere ụkpụrụ a tụrụ aro ya nwere ike ibute hypoglycemia, allergies ma ọ bụ ịxụ ahụ.

Ekwesịrị ịnye ọgwụ ahụ ozugbo tupu nri ugboro isii 4-6 n'ụbọchị. Ọ bụrụ na a na-eme onye ọrịa ahụ ọgwụ insulin na-eme ogologo oge, oge nchịkwa nke ọgwụ Humalog nwere ike belata ugboro 1-3, dabere na ọkwa shuga n'oge dị iche iche nke ụbọchị yana atụmatụ ndị ọzọ nke usoro ịrịa ọrịa shuga.

Ngwurugwu mgbochi na nsonaazụ ya

Nanị ihe contraindication lyspro insulin bụ hypoglycemia. N'oge ime na lact, a na-enye ọgwụ ọgwụ a naanị mgbe ọ nyochachara ọkachamara na-ahụ maka ịmị amụ nwa na nwanyị. N'ihi njirimara anụ ahụ nke ahụ nwanyị, mkpa nke insulin nwere ike ịgbanwe n'oge na-atụ anya nwatakịrị, yabụ, mgbe ụfọdụ, a na-achọ ndozi ma ọ bụ wepụ oge ọgwụ mgbe ụfọdụ. Amabeghị ma ọgwụ ahụ na-abanye na mmiri ara ara, ebe ọ bụ na enwebeghị ọmụmụ ọmụmụ a na-achịkwa banyere ya.

Mmetụta ndị ọzọ na ọgwụgwọ a na-eme ugboro ugboro. Ma mgbe ụfọdụ ndị ọrịa nwere ike ịnwe:

• belata ogo shuga dị n'okpuru ebe a chọrọ.
• ọzịza na ahụ erughị ala na ntụtụ ahụ,
• lipodystrophy,
• ihe odide.

Nnukwu insulin

Enwere ọgwụ ejikọtara nke nwere insulin lispro dị ọcha (homonụ nke ultrashort) na mgbatị protamine nke ihe a, nke nwere oge ihe ha na-eme. Aha ahia maka ogwu a bu Humalog Mix.

Ebe ngwaahịa a dị n'ụdị nkwusioru (ya bụ, ihe ọ liquụ partụ nwere ụmụ irighiri ihe na-enweghị isi na ya), ọ kwesịrị ịdị na-adọgharị ibe ya n'aka ya tupu etinye ya ka ọ kesaa insulin na osisa. Ekwekwala aka kpoo akpa ahụ, ebe nke a nwere ike ibute ụfụfụ ma mee ka ngụkọta kọọ nke enyere achụrụ.

Dịka ọgwụ ọ bụla maka ọrịa shuga, Humalog ga-enwe otu oge na abụọ. N'okpuru nchịkwa nke ọbara, ị nwere ike ịhọrọ ọgwụ kachasị mma, nke ga-enyere gị aka idobe onye ọrịa ahụ ma belata ihe ize ndụ nke ịmalite ọrịa. Cannweghị ike ịnwale onwe gị ozugbo na ụdị insulin ọzọ, n'ihi na nke a nwere ike ibute ahụ gị ma kpatara mbibi.

Mmetụta ikike ịkwọ ụgbọala, usoro

Site na hypoglycemia ma ọ bụ hyperglycemia nke metụtara usoro ịsingụ ọgwụ ezughị ezu, imebi ikike itinye uche na ọsọ nke mmeghachi omume psychomotor. Nke a nwere ike bụrụ ihe dị ize ndụ maka ihe egwu nwere ike ịdị (gụnyere ịnya ụgbọ ala ma ọ bụ igwe).
Ndị ọrịa kwesịrị ịkpachara anya iji zere hypoglycemia mgbe ha na-anya ụgbọala. Nke a dị mkpa ọfụma maka ndị ọrịa nwere nghọta amamịghe ma ọ bụ na-anọghị ya, nke ihe mgbaàmà na-ebute hypoglycemia, ma ọ bụ ebe enwere hypoglycemia. N'ọnọdụ ndị a, ọ dị mkpa iji chọpụta ike nke ụgbọ ala na usoro.

Mpempe mwepụta

Ngwọta maka nchịkwa intravenous na subcutaneous nke 100 IU / ml.
3 ml nke ọgwụ na katriiki nke iko dị ọcha, nke na-enweghị ụcha (ụdị nke I). Ejiri bromobutyl stopa ma jiri okpu aluminom kpuchie igbe ahụ, n'aka nke ọzọ, onye nwere eriri bromobutyl. A na-etinye katriiki 1 ma ọ bụ ise na mbadamba ihe na-acha odo odo nke ihe nkiri PVC na ihe mkpuchi nke aluminom. A na-etinye ngwugwu 1 blister tinyere ntuziaka maka iji ya n'ime igbe kaadiboodu. 10 ml nke ọgwụ na karama pan nke transperent, iko na-enweghị ụcha (ụdị nke m) na onye na-akwụsị bromobutyl ma jiri okpu aluminom gwakọta ya.
Kalama 1 tinyere ntuziaka maka iji ya na igbe kaadi.